MOL

Meghmani Organics Limited

Meghmani Organics Limited (MOL) financial statements and selected valuation metrics through 30 June 2026.

Commodities›Chemicals›Fertilizers & Agrochemicals›Pesticides & Agrochemicals

Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹59.55
Market cap
1,510 Cr
Stock P/E
23.5
P/B
0.98
Dividend yield
2.4%
ROE (FY26)
1.9%
ROCE (FY26)
6.8%
Operating margin (FY26)
2.6%
Debt / equity (FY26)
0.47
OCF / EBITDA (FY26)
125.7%
OCF / EBITDA (3Y)
179.9%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

MOL (Meghmani Organics) makes crop protection chemicals and pigments, and is adding nano-based crop nutrition products such as Nano Urea, selling mostly to export markets (about 85% of its FY26 revenue).

Company snapshot

14thBy market cap

Ranked among 23 companies in Pesticides & Agrochemicals.

Segment mix

Reportable segments as of 2024-12-31 (Consolidated). Revenue share = segment revenue ÷ total revenue.

Largest segment: 72.2% of revenue

SegmentRevenue shareRevenuePBTAssets
Agrochemicals
72.2%
411 Cr52 Cr1,840 Cr
Others
2.2%
12 Cr-2 Cr203 Cr
Pigment
28.1%
160 Cr-24 Cr1,194 Cr

Shares add up to 103% because segment revenues are before inter-segment eliminations.

What we see

Positives
  • ✓180% of operating profit came in as cash over the last three years — profits are backed by real cash.
Concerns
  • ✗Net margin is very thin at 1.3% — little room for error if costs rise.
1 more signal from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales379 Cr352 Cr410 Cr414 Cr544 Cr569 Cr553 Cr614 Cr577 Cr509 Cr474 Cr543 Cr
Operating expenses (approx.)371 Cr360 Cr408 Cr408 Cr513 Cr528 Cr488 Cr547 Cr525 Cr471 Cr455 Cr445 Cr
EBITDA8 Cr-8 Cr2 Cr6 Cr31 Cr41 Cr65 Cr67 Cr52 Cr38 Cr20 Cr98 Cr
OPM %2.0%-2.2%0.5%1.4%5.6%7.2%11.8%10.9%9.0%7.4%4.2%18.0%
Other income12 Cr10 Cr9 Cr9 Cr12 Cr9 Cr14 Cr17 Cr28 Cr15 Cr37 Cr12 Cr
Interest13 Cr27 Cr2 Cr11 Cr26 Cr13 Cr19 Cr29 Cr24 Cr18 Cr20 Cr13 Cr
Depreciation23 Cr23 Cr23 Cr23 Cr25 Cr30 Cr29 Cr30 Cr30 Cr30 Cr29 Cr30 Cr
Profit before tax-16 Cr-48 Cr-14 Cr-19 Cr-9 Cr7 Cr31 Cr24 Cr26 Cr5 Cr7 Cr67 Cr
Tax %2.8%20.3%-25.4%13.3%-1.1%159.3%35.1%47.8%55.7%178.3%-12.4%28.1%
Net profit-15 Cr-38 Cr-18 Cr-17 Cr-9 Cr-4 Cr20 Cr13 Cr12 Cr-4 Cr8 Cr48 Cr
EPS (₹)₹-0.60₹-1.50₹-0.71₹-0.25₹-0.36₹-0.17₹0.78₹0.50₹0.45₹-0.14₹0.32₹1.90

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales2,498 Cr2,553 Cr1,566 Cr2,080 Cr2,174 CrSign in free for the trailing twelve months
Operating expenses (approx.)2,120 Cr2,212 Cr1,587 Cr1,937 Cr1,998 CrSign in free for the trailing twelve months
EBITDA379 Cr341 Cr-20 Cr143 Cr176 CrSign in free for the trailing twelve months
OPM %15.1%13.4%-1.3%6.9%8.1%Sign in free for the trailing twelve months
Other income96 Cr96 Cr38 Cr44 Cr96 CrSign in free for the trailing twelve months
Interest9 Cr66 Cr46 Cr69 Cr92 CrSign in free for the trailing twelve months
Depreciation63 Cr77 Cr92 Cr108 Cr119 CrSign in free for the trailing twelve months
Profit before tax409 Cr313 Cr-121 Cr9 Cr62 CrSign in free for the trailing twelve months
Tax %25.5%24.1%12.5%211.9%53.7%Sign in free for the trailing twelve months
Net profit304 Cr238 Cr-106 Cr-11 Cr29 CrSign in free for the trailing twelve months
EPS (₹)₹11.97₹9.35₹-4.17₹-0.42₹1.13Sign in free for the trailing twelve months
Dividend payout %11.7%15.0%——0.0%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital25 Cr25 Cr25 Cr25 Cr25 Cr
Reserves1,441 Cr1,644 Cr1,502 Cr1,490 Cr1,519 Cr
Borrowings495 Cr820 Cr835 Cr829 Cr726 Cr
Other liabilities837 Cr709 Cr678 Cr741 Cr750 Cr
Total liabilities2,798 Cr3,198 Cr3,040 Cr3,085 Cr3,021 Cr
Fixed assets (net)907 Cr1,164 Cr1,150 Cr1,563 Cr1,484 Cr
CWIP181 Cr346 Cr509 Cr77 Cr79 Cr
Investments211 Cr183 Cr114 Cr3 Cr5 Cr
Loans & advances0.48 Cr0.39 Cr0.27 Cr0.40 Cr0.41 Cr
Inventories639 Cr652 Cr517 Cr599 Cr529 Cr
Trade receivables543 Cr523 Cr433 Cr567 Cr672 Cr
Cash & bank10 Cr31 Cr17 Cr23 Cr16 Cr
Other assets305 Cr299 Cr300 Cr253 Cr237 Cr
Total assets2,798 Cr3,198 Cr3,040 Cr3,085 Cr3,021 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity65 Cr204 Cr250 Cr66 Cr222 Cr
Cash from investing-133 Cr-418 Cr-178 Cr31 Cr-38 Cr
Cash from financing58 Cr234 Cr-85 Cr-91 Cr-190 Cr
Net cash flow-10 Cr21 Cr-14 Cr6 Cr-7 Cr
Free cash flow (OCF − Capex)-179 Cr-261 Cr-17 Cr-23 Cr177 Cr

Ratios

MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %21.3%15.2%-3.2%3.3%6.8%
ROE %20.8%14.2%-6.9%-0.7%1.9%
Debtor days797510199113
Inventory days146156209170154
Days payable131107199156158
Cash conversion cycle94124110113109
OCF / EBITDA %17.1%60.0%—46.4%125.7%
OCF / EBITDA % (3 years)——74.2%112.3%179.9%
Debt / equity0.340.490.550.550.47
Current ratio1.391.421.151.121.07
Net debt / EBITDA1.282.31—5.654.02